Bryce Beverlin Ii

Principal investigator.

Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$5.4MFederal grants as PI8 awards
0Patents grantedNone matched
0PapersOpenAlex
Career record

Federal awards and patents by year

20182024
AwardsPatents
Federal awards as principal investigator

8 awards · $5.4M

DateAgencyAwardAmountCompany
May 24, 2024NIHSBIR Phase I
A novel inhaled dry powder psychoplastogenic formulation for treating persons with opioid use disorder
$405KQUENCH MEDICAL, INC.
Mar 12, 2024NIHSBIR Phase II
Treating non-small cell lung tumors with a novel inhaled dry powder chemotherapeutic formulation
$874KQUENCH MEDICAL, INC.
Mar 30, 2023NIHSBIR Phase II
Treating non-small cell lung tumors with a novel inhaled dry powder chemotherapeutic formulation
$1.1MQUENCH MEDICAL, INC.
Feb 8, 2023NIHSBIR Phase I
Stop pulmonary airleaks with a novel inhaled dry powder aerosol
$300KQUENCH MEDICAL, INC.
Sep 6, 2021NIHSBIR Phase II
Treating severe asthma in the small airways with a highly efficient and penetrating inhaled dry powder
$802KQUENCH MEDICAL, INC.
Aug 14, 2020NIHSBIR Phase I
Treating non-small cell lung tumors with a novel inhaled dry powder chemotherapeutic formulation
$400KQUENCH MEDICAL, INC.
Aug 10, 2020NIHSBIR Phase II
Treating severe asthma in the small airways with a highly efficient and penetrating inhaled dry powder
$1.2MQUENCH MEDICAL, INC.
Mar 1, 2018NIHSBIR Phase I
Treating severe asthma in the small airways: a novel inhaled dry powder formulation
$225KQUENCH MEDICAL, INC.
Among 4,795 researchers in Medtech

Peer ranks

Federal funding#254
Awards as PI#216
Patents#505
From filings, awards and patents

Companies

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.